By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
The Aspiration Catheter (VX) is intended to provide an efficient and effective thrombus removal option. Exceptional trackability, push ability, and aspiration volume. The Aspiration Catheter is a quick exchange type catheter used for percutaneous suction removal of thrombus and debris from the coronary or peripheral arteries.
In mechanical thrombectomy treatments, aspiration catheters, also known as intermediate or distal access catheters, are usually used to accomplish direct contact aspiration (a direct aspiration first pass method, ADAPT) or a combination approach with a sterndrives.
Aspiration catheters are directed via the vascular architecture to reach the occlusion location in both technical procedures. The catheter’s proximal end is then linked to a syringe or aspiration pump that provides negative pressure to engage or consume the target.
As a result, the primary performance criteria for distal access catheters are ease of navigation and successful aspiration. The major components of navigability are trackability (the ability to progress over a rail to reach the target spot) and push ability (the ability to transmit a push force from the device’s proximal to distal end).
Furthermore, because vascular architecture can be exceedingly convoluted, the catheter shaft should be kink-resistant while crossing tight twists. These properties are achieved by modifying the design of the four catheter elements: inner liner, reinforcement, outer jacket, and hydrophilic coating.
To improve trackability, the liner should be composed of a low-friction substance such as polytetrafluoroethylene, also known as PTFE.
Furthermore, the outer jacket consisting of polymers of variable composition allows for additional catheter flexibility modification, and the hydrophilic coating on the polymer jacket can improve the device’s lubricity, i.e. minimize friction between catheter and vessel walls, during navigation.
The reinforcement requires a braided structure that promotes force transfer along the catheter shaft; and the reinforcement requires a coil structure that offers flexibility and hoop strength to boost kink and novelization resistance.
The Global Aspiration Catheter Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Penumbra, Inc., a global healthcare business focused on novel medicines, announced the clearance and introduction of Lightning Flash, the most sophisticated and powerful mechanical thrombectomy device on the market, with the U.S. Food and Drug Administration (FDA).
Lightning Flash incorporates Penumbra’s groundbreaking Lightning Intelligent Aspiration technology, which now includes dual clot detection algorithms.
Lightning Flash, in conjunction with revolutionary catheter architecture, is intended to rapidly remove big blood clots in the body, such as venous thrombus and pulmonary emboli (PE).
Because of Lightning’s computer-aided algorithms, Penumbra’s Lightning Flash provides clinicians with a highly torqueable, bigger catheter that is meant to remove a substantial clot burden in the pulmonary arteries or deep venous system more effectively while retaining an outstanding safety profile.
Lightning Flash, driven by the Penumbra ENGINE®, detects blood clots and blood flow using both pressure and flow-based algorithms. The Lightning Flash catheter is built with Max ID hypo tube technology, which allows for an inner diameter comparable to large-bore catheters while keeping a reduced profile and a soft, atraumatic tip meant to aid in navigating the body’s intricate and delicate structure. The gadget is meant to assist clear blood clots fast while minimizing possible blood loss when used simultaneously.
